Catalyst Wire Dossier Catalyst Wire Dossier

BNX Sublingual Tablets

buprenorphine-naloxone · Orexo AB
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BNX Sublingual Tablets, covering 2015-05-22 to 2015-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence [Phase 3]

See pricing